US Patent Issued to Multitude on May 27 for "Antibodies specific to CD44" (Chinese, American Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,031, issued on May 27, was assigned to Multitude Inc. (Shanghai).

"Antibodies specific to CD44" was invented by Shaofei Zhang (Shanghai), Bing Hou (Shanghai), Guangcun Cheng (Shanghai), Shu-Hui Liu (Redwood City, Calif.) and Xun Meng (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies having binding specificity to CD44 v7/8, (a.k.a. CD44 variant 7/8) and antibody-drug conjugates (ADCs) or chimeric antigen receptors comprising such. Also provided herein are uses the anti-CD44 v7/8 antibodies, the ADCs, or immune cells expressing the chimeric antigen receptors for therapeutic and diagnostic purposes."

The patent was filed on July 27, ...